Condition: Mitral Regurgitation · Mitral Stenosis · Sponsor: Abbott Medical Devices
The objective of this study is to evaluate the preliminary safety and effectiveness of the Cephea Mitral Valve System for the treatment of symptomatic patients with mitral valve disease (including mitral regurgitation, mitral stenosis and mixed mitral valve disease) in whom transcatheter therapy is deemed more appropriate than open heart surgery.
This description comes directly from the study's public registry record.
Leslie Centeno · +1 818-294-3041 · leslie.centeno@abbott.com
Clinical Project Manager · Cephea_FS@abbott.com
Always discuss trial participation with your own doctor first.
| Instituto do Coracao (InCor) - HCFMUSP | São Paulo, Brazil | Recruiting |
| Instituto Nacional del Torax | Santiago, Chile | Recruiting |
| Hospital Clinico San Borja Arriarán | Santiago, Chile | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07244939